Safety and Effectiveness of BufferGel and 0.5% PRO2000 Gel for the Prevention of HIV Infection in Women

Lignende værker

• Utility of colposcopy in a phase 2 portion of a microbicide clinical trial of BufferGel and 0.5% PRO 2000 Gel
  af: Chirenje, Zvavahera M, et al.
  Udgivet: (2012)
• HPTN 035 Phase II/IIb Randomized Safety and Effectiveness Study of the Vaginal Microbicides BufferGel and 0.5% PRO 2000 for the Prevention of Sexually Transmitted Infections in Women
  af: Guffey, M. Bradford, et al.
  Udgivet: (2014)
• Mucosal Escherichia coli Bactericidal Activity and Immune Mediators Are Associated With HIV-1 Seroconversion in Women Participating in the HPTN 035 Trial
  af: Dezzutti, Charlene S., et al.
  Udgivet: (2012)
• Appropriateness of hydroxyethylcellulose gel as a placebo control in vaginal microbicide trials: A comparison of the two control arms of HPTN 035
  af: Richardson, Barbra A., et al.
  Udgivet: (2013)
• Oral and injectable contraceptive use and HIV acquisition risk among women in 4 African countries: a secondary analysis of data from a microbicide trial
  af: Balkus, Jennifer E., et al.
  Udgivet: (2015)